探讨微创锥颅软通道引流治疗高血压脑出血患者的临床疗效

Clinical Effect of Minimally Invasive Soft Channel Drainage in Patients with Hypertensive Intracerebral Hemorrhage

目的:探讨微创锥颅软通道引流治疗高血压脑出血患者的临床疗效。方法:选取某院2013年1月~2017年5月收治的高血压脑出血患者112例,按照随机数字表法将其分为研究组和对照组,对比分析两组患者临床治疗效果和并发症发生率。结果:在治疗效果对比中,研究组患者治疗总有效率为98.22%,对照组患者治疗总有效率为83.93%,进行统计学对比分析后可知P<0.05,统计学意义显著;在并发症对比中,研究组患者并发症发生率为0,对照组患者并发症发生率为10.71%,组间对比差异具有统计学意义,P<0.05。结论:微创锥颅软通道引流治疗高血压脑出血患者的治疗效果更佳,无并发症发生,具有较高的临床应用价值。

Objective：To investigate the clinical efficacy of minimally invasive transcranial soft drainage in patients with hypertensive intracerebral hemorrhage.Methods：112 patients with hypertensive intracerebral hemorrhage treated in a hospital from January 2013 to May 2017 were were selected and randomly divided into study group and control group,and the clinical curative effect and the incidence of complications in the two groups were compared.Results：In the contrast of treatment effect,the total effective rate of treatment in the study group was 98.22%,and the total effective rate of the control group was 83.93%.After statistical analysis,P〈0.05 was found.The statistical significance was significant.The incidence of complications was 0 in the study group and 10.71%in the control group.The difference between the two groups was statistically significant（P〈0.05）.Conclusion：Minimally invasive transcranial soft channel drainage is better in the treatment of hypertensive intracerebral hemorrhage,without complications,which has high clinical application value.